TRxADE HEALTH Inc. (MEDS) Social Stream

Featured Post From StockTwits About MEDS

$MEDS nice check BHVN at $107.90 at $7B value

95% migraine patients can take Nurtec for acute or chronic use

$800 per rx

12.8% prevalence rate in america
with some worst case assumptions:
30% chronic, 70% acute
only 1 rx for acute per year

10% of migraine patients taking it
cut the price of rx by 50%.. $400

quick math shows over $7 billion revenue yes BILLION

now try to do more realistic assumptions and add other pipeline stocks in coming years

do you now see $500 to $800 stock price here?

97% float is own by institutions
There is no shares avail. stock can do +/- $10 in minutes with small sell/buy orders.
accumulate as much as you can. Hope we see $80s and $90s.